Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.
暂无分享,去创建一个
J. Drazen | M. Kaliner | C. Lilly | M. Rosenberg | A. Fischer | Y. Igarashi | M. White | P. Rubin | J. Callery | J. Cohn | J. C. Callery
[1] J. Oates,et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. , 1994, American journal of respiratory and critical care medicine.
[2] E. Israel,et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. , 1993, The American review of respiratory disease.
[3] S. Dahlén,et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. , 1993, The European respiratory journal.
[4] K. Sladek,et al. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. , 1993, The European respiratory journal.
[5] M. Kowalski,et al. Nasal secretions in response to acetylsalicylic acid. , 1993, The Journal of allergy and clinical immunology.
[6] A. Ford-hutchinson,et al. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. , 1992, The American review of respiratory disease.
[7] S. Dahlén,et al. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. , 1992, The American review of respiratory disease.
[8] J. Shelhamer,et al. Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells. , 1992, The Journal of allergy and clinical immunology.
[9] L. Schwartz. Cellular inflammation in asthma: neutral proteases of mast cells. , 1992, The American review of respiratory disease.
[10] J. Montserrat,et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. , 1992, The American review of respiratory disease.
[11] G. FitzGerald,et al. Increased excretion of leukotriene E4 during aspirin-induced asthma. , 1992, The Journal of laboratory and clinical medicine.
[12] J. Denburg,et al. Histochemical and immunohistochemical characteristics of mast cells in nasal polyps. , 1992, American journal of respiratory cell and molecular biology.
[13] D. Stevenson,et al. Tryptase and histamine release during aspirin-induced respiratory reactions. , 1991, The Journal of allergy and clinical immunology.
[14] T. Lee,et al. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. , 1991, The American review of respiratory disease.
[15] A. Ford-hutchinson,et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. , 1991, The American review of respiratory disease.
[16] R. D. Dyer,et al. 5-lipoxygenase inhibitory activity of zileuton. , 1991, The Journal of pharmacology and experimental therapeutics.
[17] L. Dubé,et al. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase. , 1991, Agents and actions. Supplements.
[18] H. Knapp,et al. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. , 1990, The New England journal of medicine.
[19] A. Kagey‐Sobotka,et al. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells. , 1990, The American review of respiratory disease.
[20] T. Yamashita,et al. Etiology of nasal polyps associated with aspirin-sensitive asthma. , 1989, Rhinology. Supplement.
[21] L. Schwartz,et al. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response. , 1988, The Journal of allergy and clinical immunology.
[22] D. Stevenson,et al. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. , 1988, The American review of respiratory disease.
[23] K. Hozawa,et al. Mast cell degranulation in nasal polyps. , 1986, Acta oto-laryngologica. Supplementum.
[24] A. Togias,et al. Inflammatory mediators in late antigen-induced rhinitis. , 1985, The New England journal of medicine.
[25] L. Schwartz. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. , 1985, Journal of immunology.
[26] R. Naclerio,et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.
[27] E. Corey,et al. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Nowak. Eicosanoids and the lungs. , 1984, Annals of clinical research.
[29] J. Delaney. The effect of ketotifen on aspirin‐induced asthmatic reactions , 1983, Clinical allergy.
[30] J. Shelhamer,et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. , 2015, The American review of respiratory disease.
[31] S. Dahlén,et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Szczeklik,et al. Inhibition by Ketotifen of Idiosyncratic Reactions to Aspirin , 1980, Allergy.
[33] E. Corey,et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Szczeklik,et al. Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. , 1979, Thorax.
[35] I. Olsson,et al. Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. , 1977, Laboratory investigation; a journal of technical methods and pathology.
[36] E. Tan,et al. Oral aspirin challenges in asthmatic patients: a study of plasma histamine , 1976, Clinical allergy.
[37] A. Szczeklik,et al. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. , 1975, British medical journal.